BiotechTube
Biologics Corp

Biologics Corp

San Diego, United States· Est.
biologicscorp.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BiologicsCorp is a privately-held, revenue-generating service provider in the biologics sector, specializing in custom recombinant protein and antibody production. It leverages a multi-platform technology suite encompassing bacterial, mammalian, yeast, and insect expression systems to deliver rapid, high-quality, and cost-effective solutions for its clients. The company's business model is built on providing essential R&D services to the broader life sciences industry, positioning it as a key enabler for drug discovery and development programs. Its value proposition emphasizes competitive pricing, a risk-free delivery guarantee, and a focus on building long-term client partnerships.

BiologicsAntibodiesDrug Delivery

Technology Platform

Multi-system recombinant protein and antibody expression platform (bacterial, mammalian, yeast, insect), recombinant antibody engineering (full-length, fragments, Fc-fusion), stable cell line construction, biomolecular interaction analysis (label-free kinetics).

Opportunities

Sustained growth in biologics R&D creates steady demand for protein production services.
The rise of virtual biotechs and academic research reliant on outsourcing provides a expanding client base.
Increasing complexity of next-generation biologics (bispecifics, ADCs) requires specialized expertise that niche CROs can provide.

Risk Factors

High competition in the CRO/CDMO space pressures pricing and margins.
Revenue is tied to client R&D budgets, which are cyclical and can shrink during funding downturns.
Operational risk from the 'no delivery, no charge' model and the need for continuous investment to keep technology competitive.

Competitive Landscape

BiologicsCorp competes in a fragmented market with numerous players, including large global CDMOs (e.g., Lonza, Catalent), specialized protein service providers (e.g., GenScript, ProteoGenix), and many small regional labs. Its differentiation is based on competitive pricing, a risk-free guarantee, and a broad multi-platform service menu, but it lacks the scale and GMP manufacturing depth of larger competitors.

More companies in Biologics / Biosimilars →More companies in United States →